Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium-99m stannous colloid
- Development stage
- Unknown
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
**Technetium-99m stannous colloid** is a diagnostic radiopharmaceutical consisting of technetium-99m associated with stannous colloid particles. It is used principally to label autologous leukocytes ex vivo for white-cell scintigraphy. Neutrophils and monocytes phagocytose the colloid, after which the radiolabeled cells can localize to inflammatory or infectious sites and be detected by gamma-camera imaging. Published studies describe its use for imaging inflammation, occult infection, inflammatory bowel disease activity, and gram-negative infection-associated alterations in leukocyte phagocytic function. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/15691667/))
- Other names
- 99mTc Sn colloid99mTc SnC99mTc-stannous colloidtechnetium Tc 99m tin colloidtechnetium-99m stannous colloidtechnetium99m stannous colloidtechnetium 99m stannous colloidtechnetium-99m tin colloidtechnetium99m tin colloidtechnetium 99m tin colloid
02
Targets
αMβ2 (Integrin αMβ2)
Beyond the preview
Go deeper on technetium-99m stannous colloid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium-99m stannous colloid.